BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 4164884)

  • 1. Mechanisms of the inhibition of chemotaxis by phosphonate esters.
    Ward PA; Becker EL
    J Exp Med; 1967 Jun; 125(6):1001-20. PubMed ID: 4164884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Partial biochemical characterization of the activated esterase required in the complement-dependent chemotaxis of rabbit polymorphonuclear leukocytes.
    Becker EL; Ward PA
    J Exp Med; 1967 Jun; 125(6):1021-30. PubMed ID: 6025317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The deactivation of rabbit neutrophils by chemotactic factor and the nature of the activatable esterase.
    Ward PA; Becker EL
    J Exp Med; 1968 Apr; 127(4):693-709. PubMed ID: 5642465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Esterases of the polymorphonuclear leukocyte capable of hydrolyzing acetyl DL-phenyl-alanine beta-naphthyl ester. Relationship to the activatable esterase of chemotaxis.
    Becker EL; Ward PA
    J Exp Med; 1969 Mar; 129(3):569-84. PubMed ID: 5812915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The requirement of serine esterase function in complement-dependent erythrophagocytosis.
    Pearlman DS; Ward PA; Becker EL
    J Exp Med; 1969 Oct; 130(4):745-64. PubMed ID: 5343432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemotoxis of mononuclear cells.
    Ward PA
    J Exp Med; 1968 Nov; 128(5):1201-21. PubMed ID: 5682943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship of the chemotactic behavior of the complement-derived factors, C3a, C5a, and C567, and a bacterial chemotactic factor to their ability to activate the proesterase 1 of rabbit polymorphonuclear leukocytes.
    Becker EL
    J Exp Med; 1972 Feb; 135(2):376-87. PubMed ID: 4551218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. THE ROLE OF SERUM COMPLEMENT IN CHEMOTAXIS OF LEUKOCYTES IN VITRO.
    WARD PA; COCHRANE CG; MUELLER-EBERHARD HJ
    J Exp Med; 1965 Aug; 122(2):327-46. PubMed ID: 14316948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The chemosuppression of chemotaxis.
    Ward PA
    J Exp Med; 1966 Aug; 124(2):209-26. PubMed ID: 5950689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of immunologic injury of rat peritoneal mast cells. II. Complement requirement and phosphonate ester inhibition of release of histamine by rabbit anti-rat gamma globulin.
    Austen KF; Becker EL
    J Exp Med; 1966 Sep; 124(3):397-416. PubMed ID: 4162486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C3 leukotactic factors produced by a tissue protease.
    Hill JH; Ward PA
    J Exp Med; 1969 Sep; 130(3):505-18. PubMed ID: 4185247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of immunologic injury of rat peritoneal mast cells. I. The effect of phosphonate inhibitors on the homocytotropic antibody-mediated histamine release and the first component of rat complement.
    Becker EL; Austen KF
    J Exp Med; 1966 Sep; 124(3):379-95. PubMed ID: 4162485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on crystal-induced chemotactic factor. II. Role of phagocytosis.
    Spilberg I; Gallacher A; Mendell B
    J Lab Clin Med; 1975 Apr; 85(4):631-6. PubMed ID: 1120930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The action of phosphonates on the leucocyte in relation to the mode of action of leucocidin. The properties of the potassium pump and the inhibition of chemotaxis.
    Woodin AM; Wieneke AA
    Br J Exp Pathol; 1969 Jun; 50(3):295-308. PubMed ID: 5797384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation of an N-acetyl-DL-phenylalanine beta-naphthyl esterase from rabbit peritoneal polymorphonuclear leukocytes.
    Tsung P; Kegeles SW; Showell HJ; Becker EL
    Biochim Biophys Acta; 1975 Sep; 403(1):98-105. PubMed ID: 240431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Organophosphorus inhibition of lysosomal enzyme secretion from polymorphonuclear leucocytes. Evidence of a lack of a requirement for esterase activation.
    Becker EL; Koza EP; Sigman M
    Immunology; 1978 Aug; 35(2):373-80. PubMed ID: 750374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biological activity of complement in vivo. Role of C5 in the accumulation of polymorphonuclear leukocytes in inflammatory exudates.
    Snyderman R; Phillips JK; Mergenhagen SE
    J Exp Med; 1971 Nov; 134(5):1131-43. PubMed ID: 5112201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific inhibition of the polymorphonuclear leukocyte chemotactic response to hydroxy-fatty acid metabolites of arachidonic acid by methyl ester derivatives.
    Goetzl EJ; Valone FH; Reinhold VN; Gorman RR
    J Clin Invest; 1979 Jun; 63(6):1181-6. PubMed ID: 447841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A plasmin-split fragment of C'3 as a new chemotactic factor.
    Ward PA
    J Exp Med; 1967 Aug; 126(2):189-206. PubMed ID: 4226271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The inhibition of locomotion of the polymorphonuclear leucocyte by organophosphorus compounds.
    Woodin AM; Harris A
    Exp Cell Res; 1973 Mar; 77(1):41-6. PubMed ID: 4690172
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.